Analyst firms · Barclays · HP
Barclays HP price target and rating history
Helmerich & Payne Inc. (HP) · Energy
Barclays rates Helmerich & Payne Inc. (HP) Overweight with a $25 price target, as of its latest action on Sep 22, 2025. It has published 4 rating actions on HP since October 2021, including 2 upgrades and 1 downgrade. Across 5 firms with a HP price target in the last 12 months, the median target is $38.
- Current rating
- Overweight
- Price target
- $25
- Median target, all firms
- $38
- Actions on HP
- 4
Barclays price target on HP
Every Barclays rating on HP
- Sep 22, 2025
- Jan 10, 2024
- Jul 14, 2022
- Oct 25, 2021
How other firms rate HP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $49 | Oct 2, 2026 |
| Evercore ISI | Outperform | $43 | Mar 20, 2026 |
| TD Cowen | Hold | $38 | Feb 9, 2026 |
| Piper Sandler | Overweight | $35 | Dec 18, 2025 |
| Goldman Sachs | Neutral | $28 | Nov 21, 2025 |
Questions about Barclays and HP
- What is Barclays's price target for HP?
- Barclays's latest stated price target for Helmerich & Payne Inc. (HP) is $25, from its action on Sep 22, 2025.
- What is Barclays's rating on HP?
- Barclays rates HP Overweight, a bullish rating, as of Sep 22, 2025.
- When did Barclays last change its view on HP?
- On Sep 22, 2025, Barclays upgrades to Overweight from Equal Weight, price target $25.
- How does Barclays's HP target compare with other analysts?
- Across 5 firms with a HP price target in the last 12 months, the median target is $38.
More HP rating histories
- Evercore ISI3
- TD Cowen4
- Piper Sandler4
- Citigroup5
- Morgan Stanley7
- The Benchmark Company4
- Seaport Research Partners3
- RBC Capital Markets3
All Barclays ratingsHP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.